Zeiss Microscope Dust Covers
Navigation Links
Zeiss Microscope Dust Covers
| Products | Zeiss Microscope Dust Covers |
| Company | Carl Zeiss MicroImaging, Inc. |
| Item | Zeiss Microscope Dust Covers |
| Features | |
| Description | Dust covers for a variety of Zeiss microscopes |
| Info | Carl Zeiss MicroImaging, Inc. Customer Service: (800) 233-2343 Web site: http://www.zeiss.com/micro |
Related medicine products :
1. Carl Zeiss Cold-light illumination for Head-worn Loupes
2. ACCU-Beam® Universal Digital Camera Adaptor (Zeiss® OPMI®/Slit Lamp)
3. ACCU-Beam® Coolpix Digital Camera Adaptor (Zeiss® OPMI®/Slit Lamp Adaptor)
4. Carl Zeiss WASCA Analyzer/Aberrometer
5. Zeiss Filter Sets
6. The UHTS system from Carl Zeiss Jena
7. Zeiss® Z-55 Style Surgical Microscope Adapter from ImagingPlanet
8. Zeiss® Z-80 Style Surgical Microscope Adapter from ImagingPlanet
9. Zeiss Z-80 Style Surgical Microscope Video Adapter from ImagingPlanet
10. Zeiss Z-55 Style Surgical Microscope Video Adapter from ImagingPlanet
11. Zeiss Z-70 Style Surgical Microscope Video Adapter from ImagingPlanet
Breaking Medicine News(10 mins):Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients 2Health News:Anthem Blue Cross and Blue Shield in Maine and National Council on Aging Provide Vital Benefits Information to Economically Challenged Older Adults 2
[0] U.S. Cancer Cases, Deaths Continue to Drop [1] Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. [1] Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange[1] Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients[0] Anthem Blue Cross and Blue Shield in Maine and National Council on Aging Provide Vital Benefits Information to Economically Challenged Older Adults
Other Medicine News:Health News:Study Underway to Identify Genes Contributing to Heart Attack Risk 2Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 2Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 3Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 4
Study Underway to Identify Genes Contributing to Heart Attack RiskGeneral Practitioners' 'pay' In the News !New Drugs Would Help Men to Play an Equal Role in ContraceptionA Stroke of Bad Luck for Vioxx'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS PreventioTamiflu: Adverse Reaction Warning, ‘a Must’, Canada Tells Roc
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7EntreMed Reports Second Quarter 2009 Financial Results 53818 1EntreMed Reports Second Quarter 2009 Financial Results 53818 2EntreMed Reports Second Quarter 2009 Financial Results 53818 3EntreMed Reports Second Quarter 2009 Financial Results 53818 4SXC Health solutions announces record second quarter financial results 53815 1SXC Health solutions announces record second quarter financial results 53815 2SXC Health solutions announces record second quarter financial results 53815 3SXC Health solutions announces record second quarter financial results 53815 4SXC Health solutions announces record second quarter financial results 53815 5SXC Health solutions announces record second quarter financial results 53815 6SXC Health solutions announces record second quarter financial results 53815 7SXC Health solutions announces record second quarter financial results 53815 8SXC Health solutions announces record second quarter financial results 53815 9SXC Health solutions announces record second quarter financial results 53815 10SXC Health solutions announces record second quarter financial results 53815 11SXC Health solutions announces record second quarter financial results 53815 12SXC Health solutions announces record second quarter financial results 53815 13SXC Health solutions announces record second quarter financial results 53815 14SXC Health solutions announces record second quarter financial results 53815 15SXC Health solutions announces record second quarter financial results 53815 16SXC Health solutions announces record second quarter financial results 53815 17SXC Health solutions announces record second quarter financial results 53815 18SXC Health solutions announces record second quarter financial results 53815 19Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 1Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 2Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 3Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 4Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 5Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 6Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 7Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 8
[0] Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million[0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors[0] Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |